Skip to main content
ImmuneCited

Beta-Glucan के लिए Upper Respiratory Tract Infections

A

Meta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dbeta\u002Dglucan\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Meta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.

Key Study Findings

Randomized Controlled Trial
The anti-infective effect of β-glucans in children.
Dose: 10 mg बनाम: Placebo Outcome: Body weight प्रभाव: None None

जनसंख्या: None

In Vitro
Dry blood spot samples to monitor immune-associated mRNA expression in intervention studies: Impact of Baker's …
Dose: 250 mg/d बनाम: None Outcome: oxidative stress markers प्रभाव: None None

जनसंख्या: None

Randomized Controlled Trial 12 weeks Double-blind
β -Glucan Improves Protective Qi Status in Adults with Protective Qi Deficiency-A Randomized, Placebo-Controlled, and …
Dose: None बनाम: Placebo Outcome: Protective Qi status improvement प्रभाव: None None

जनसंख्या: Adults with Protective Qi deficiency

Meta-Analysis
Effects of yeast β-glucans for the prevention and treatment of upper respiratory tract infection in …
Dose: 95% बनाम: placebo Outcome: None प्रभाव: OR = 0.345 p < 0.001

जनसंख्या: healthy subjects

Randomized Controlled Trial n=69
Soluble and Insoluble Yeast β-Glucan Differentially Affect Upper Respiratory Tract Infection in Marathon Runners: A …
Dose: 250 mL/d बनाम: Placebo Outcome: None प्रभाव: None None

जनसंख्या: URTI patients

Randomized Controlled Trial n=132 Double-blind
Beverage Containing Dispersible Yeast β-Glucan Decreases Cold/Flu Symptomatic Days After Intense Exercise: A Randomized Controlled …
Dose: 250 mL/d बनाम: Placebo Outcome: None प्रभाव: None p < .05

जनसंख्या: URTI patients

Key Statistics

13

अध्ययन

2000

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

International journal for … 2024 5 उद्धरण
Medicine and science … 2008 71 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
250-500 mg/day
immunesupport:
250-750 mg/day

अधिकतम सीमा: No established UL

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
10 mg -- Positive --
250 mg/d -- Positive --
None 12 weeks Positive --
95% -- Positive --
250 mL/d -- Mixed 69
250 mL/d -- Neutral 132
900 mg 16.0 weeks Positive 299
367 mg 12.9 weeks Positive 34

सेवन का सर्वोत्तम समय: On empty stomach for optimal immune activation

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Generally very well tolerated
  • Mild gastrointestinal effects (bloating)
  • Allergic reactions in yeast-sensitive individuals

ज्ञात अंतःक्रियाएँ

  • Immunosuppressant medications (may counteract immunosuppression)
  • Generally few known drug interactions

सहनीय अधिकतम सेवन: No established UL

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Beta-Glucan help with Upper Respiratory Tract Infections?
Based on 13 studies with 2,000 participants, there is strong evidence from multiple clinical trials that Beta-Glucan may support Upper Respiratory Tract Infections management. Our evidence grade is A (Strong Evidence).
How much Beta-Glucan should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Beta-Glucan?
Reported side effects may include Generally very well tolerated, Mild gastrointestinal effects (bloating), Allergic reactions in yeast-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Beta-Glucan and Upper Respiratory Tract Infections?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 13 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Upper Respiratory Tract Infections

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।